ORF Genetics
ORF Genetics specialises in plant biotechnology that creates high-quality recombinant proteins, including human and animal growth factors, using bioengineered barley.
ORF Genetics has raised €5.0M across 1 funding round, most recently a round in Sep 2025. Based in Kópavogur, Iceland; active in Healthtech. Data as of 28 Oct 2026.
Kópavogur, Icelandwww.orfgenetics.com ↗
Total raised
€5.0M
€5,000,000
Funding rounds
1
Investors
0
distinct backers
Active since
2025-09
latest 2025-09
Funding by year
EUR raised per yearORF Genetics — funding by year — interactive chart.
Data table
| ORF Genetics — funding by year | |
|---|---|
| 2025 | €5.0M |
Signals
Medium confidenceRaise-next likelihood46
base rate 30% for Other
- ▲ In typical raise window
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-11 | Other | €5.0M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData